Afarid M, Mahmoodi S, Baghban R (2022) Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update. J Nanobiotechnol 20:1–36
Ahmed I, Gokhale RD, Shah MV, Patton TF (1987) Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea. J Pharm Sci 76:583–586. https://doi.org/10.1002/jps.2600760802
Article CAS PubMed Google Scholar
Allen TM, Hansen CB, de Menezes DEL (1995) Pharmacokinetics of long-circulating liposomes. Adv Drug Deliv Rev 16:267–284
Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341–345
Article CAS PubMed Google Scholar
Ambati J, Adamis AP (2002) Transscleral drug delivery to the retina and choroid. Prog Retin Eye Res 21:145–151. https://doi.org/10.1016/s1350-9462(01)00018-0
Article CAS PubMed Google Scholar
Ambati J, Canakis CS, Miller JW, Gragoudas ES, Edwards A, Weissgold DJ et al (2000) Diffusion of high molecular weight compounds through sclera. Investig Ophthalmol Vis Sci 41:1181–1185
Ambati J, Gragoudas ES, Miller JW, You TT, Miyamoto K, Delori FC et al (2000) Transscleral delivery of bioactive protein to the choroid and retina. Invest Ophthalmol Vis Sci 41:1186–1191
Antonyak MA, Cerione RA (2018) The distinct traits of extracellular vesicles generated by transformed cells. Small GTPases 9:427–432. https://doi.org/10.1080/21541248.2016.1249044
Article CAS PubMed Google Scholar
Baltan S, Inman DM, Danilov CA, Morrison RS, Calkins DJ, Horner PJ (2010) Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration. J Neurosci 30:5644–5652. https://doi.org/10.1523/JNEUROSCI.5956-09.2010
Article CAS PubMed PubMed Central Google Scholar
Barenholz YC (2012) Doxil®—the first FDA-approved nano-drug: Lessons learned. J Control Release 160:117–134
Article CAS PubMed Google Scholar
Boote C, Sigal IA, Grytz R, Hua Y, Nguyen TD, Girard MJA (2020) Scleral structure and biomechanics. Prog Retin Eye Res 74:100773. https://doi.org/10.1016/j.preteyeres.2019.100773
Article CAS PubMed Google Scholar
Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–1444. https://doi.org/10.1056/NEJMoa062655
Article CAS PubMed Google Scholar
Buckingham BP, Inman DM, Lambert W, Oglesby E, Calkins DJ, Steele MR et al (2008) Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci 28:2735–2744. https://doi.org/10.1523/JNEUROSCI.4443-07.2008
Article CAS PubMed PubMed Central Google Scholar
Çağdaş M, Sezer AD, Bucak S (2014) Liposomes as potential drug carrier systems for drug delivery. Appl Nanotechnol Drug Deliv 1:1–50
Calkins DJ (2012) Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog Retin Eye Res 31:702–719. https://doi.org/10.1016/j.preteyeres.2012.07.001
Article CAS PubMed PubMed Central Google Scholar
Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076–1084
Article CAS PubMed Google Scholar
Chan HH, Wong TT, Lamoureux EL, Perera S (2015) A survey on the preference of sustained glaucoma drug delivery systems by Singaporean Chinese patients: a comparison between subconjunctival, intracameral, and punctal plug routes. J Glaucoma 24:485–492
Chen M, Li X, Liu J, Han Y, Cheng L (2015) Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model. J Control Release 203:109–117
Article CAS PubMed Google Scholar
Chong RS, Su DHW, Tsai A, Jiang Y, Htoon HM, Lamoureux EL et al (2013) Patient acceptance and attitude toward an alternative method of subconjunctival injection for the medical treatment of glaucoma. J Glaucoma 22:190–194
Cimaglia G, Votruba M, Morgan JE, André H, Williams PA (2020) Potential therapeutic benefit of NAD+ supplementation for glaucoma and age-related macular degeneration. Nutrients 12:2871
Article CAS PubMed PubMed Central Google Scholar
Coderch L, Fonollosa J, De Pera M, Estelrich J, De La Maza A, Parra J (2000) Influence of cholesterol on liposome fluidity by EPR: relationship with percutaneous absorption. J Control Release 68:85–95
Article CAS PubMed Google Scholar
de Jong OG, Kooijmans SA, Murphy DE, Jiang L, Evers MJ, Sluijter JP et al (2019) Drug delivery with extracellular vesicles: from imagination to innovation. Acc Chem Res 52:1761–1770
Article PubMed PubMed Central Google Scholar
Edelhauser HF, Rowe-Rendleman CL, Robinson MR, Dawson DG, Chader GJ, Grossniklaus HE et al (2010) Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Investig Ophthalmol Vis Sci 51:5403–5420. https://doi.org/10.1167/iovs.10-5392
Edwards A, Prausnitz MR (1998) Fiber matrix model of sclera and corneal stroma for drug delivery to the eye. AIChE J 44:214–225
Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE et al (2020) Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev 159:332–343
Article CAS PubMed Google Scholar
Escudier B, Dorval T, Chaput N, André F, Caby M-P, Novault S et al (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med 3:1–13
Fan Z, Xiao K, Lin J, Liao Y, Huang X (2019) Functionalized DNA enables programming exosomes/vesicles for tumor imaging and therapy. Small 15:e1903761. https://doi.org/10.1002/smll.201903761
Article CAS PubMed Google Scholar
Fung AE, Rosenfeld PJ, Reichel E (2006) The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90:1344–1349. https://doi.org/10.1136/bjo.2006.099598
Article CAS PubMed PubMed Central Google Scholar
Gan WB, Grutzendler J, Wong WT, Wong RO, Lichtman JW (2000) Multicolor “DiOlistic” labeling of the nervous system using lipophilic dye combinations. Neuron. https://doi.org/10.1016/s0896-6273(00)00031-3
Gao X, Ran N, Dong X, Zuo B, Yang R, Zhou Q et al (2018) Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy. Sci Transl Med 10:eaat0195
Gao ZS, Zhang CJ, Xia N, Tian H, Li DY, Lin JQ et al (2021) Berberine-loaded M2 macrophage-derived exosomes for spinal cord injury therapy. Acta Biomater 126:211–223. https://doi.org/10.1016/j.actbio.2021.03.018
Article CAS PubMed Google Scholar
Gaurav I, Thakur A, Iyaswamy A, Wang X, Chen X, Yang Z (2021) Factors affecting extracellular vesicles based drug delivery systems. Molecules 11:1544. https://doi.org/10.3390/molecules26061544
Gomez-Ulla F, Basauri E, Arias L, Martinez-Sanz F (2009) Management of intravitreal injections. Arch Soc Esp Oftalmol 84:377–388. https://doi.org/10.4321/s0365-66912009000800003
Article CAS PubMed Google Scholar
Guo M, Wu F, Hu G, Chen L, Xu J, Xu P et al (2019) Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion. Sci Transl Med 11:eaat5690
Article CAS PubMed Google Scholar
Gustavsson ST, Enz TJ, Tribble JR, Nilsson M, Lindqvist A, Lindén C et al (2023) Nicotinamide prevents retinal vascular dropout in a rat model of ocular hypertension and supports ocular blood supply in glaucoma patients. Investig Ophthalmol Vis Sci 64:34–34
Haga H, Yan IK, Takahashi K, Matsuda A, Patel T (2017) Extracellular vesicles from bone marrow-derived mesenchymal stem cells improve survival from lethal hepatic failure in mice. Stem Cells Transl Med 6:1262–1272
Article CAS PubMed PubMed Central Google Scholar
Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z et al (2015) Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release 207:18–30
留言 (0)